Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 2011

View Archived Issues

Finasteride reduces priapism in young males with sickle cell disease

Updated preclinical and clinical data presented on antiviral CMX-001

Scientists at Eiger BioPharmaceuticals prepare new azaindazoles for HCV infections

Novel protein kinase inhibitors disclosed

Neuropeptide Y2 receptor agonists described by Roche as useful for metabolic disorders

JNJ-37822681 shows efficacy and promising metabolic profile in phase II trial in schizophrenia

Nizatidine improves symptoms of functional dyspepsia

Tofacitinib is efficacious in phase II trial in ulcerative colitis

RBM acquires biomarker research from Satoris for neurodegenerative disease testing

Tekmira and BMS expand research agreement to evaluate lipid nanoparticle formulations

Biomay's BM-32 vaccine enters phase I/II skin test trial in grass pollen allergy

New activators of soluble guanylate cyclase described

Enanta Pharmaceuticals discloses novel HCV protease inhibitors

University of Michigan presents new Smac mimetics with IAP-inhibiting activity

Takeda Pharmaceutical to acquire Nycomed

FDA approves Abbott's RealTime PCR molecular test for hepatitis C

NORD grants 2011 Corporate Award to Recordati for Carbaglu

Allon presents updated phase II/III data on davunetide in progressive supranuclear palsy

SuppreMol to in-license antibody against IL-3 for rheumatoid arthritis

Evotec and Roche terminate proof-of-concept trial of EVT-101 in depression

Synergy Pharmaceuticals advances GC-C agonist program for lowering cholesterol

WIBP and ProMetic Life Sciences expand strategic partnership agreement

Biothera initiates dosing in phase III trial of Imprime PGG with Erbitux

TxCell cleared to extend phase I/II trial of Ovasave in Crohn's disease

Enrollment begins in phase II TG-C trial in degenerative joint disease of the knee

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...